RenovoRx, Inc. (RNXT): Cash & Equivalents
$7.02M
As of 2025-12-31
$9.48M
As of 2026-06-30
+17.0%
3-year compound annual growth
+31.4%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.02M | -1.8% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $7.15M | +509.9% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $1.17M | -73.3% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $4.39M | -71.1% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $15.19M | +746.4% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $1.79M | n/a | 2022-03-30, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $7.02M | -1.8% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.14M | +15.1% |
| Flyte Aviation, Inc. (VJET) | 2025-12-31 | $88.0K | -96.9% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $5.79M | -16.2% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $1.35M | -45.6% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $87.0K | -17.7% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $11.88M | +304.7% |
| Femasys Inc (FEMY) | 2025-12-31 | $9.27M | +168.5% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $636.2K | +304.8% |
Compare RNXT, SINT, VJET, NONE. side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗